HKPD Financials

Evaluating the bottom line, Cellyan Biotechnology Co Ltd maintains a gross margin of 13.04%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 2.91%, while the net margin is 2.15%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively HKPD converts its operational activities into shareholder value.